H Vinazzer

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Substitution of antithrombin III in shock and DIC: A randomized study

B. Blauhut, H. Kramar, H Vinazzer et al. · Thrombosis Research · 1985 · 205 citations

Medicine, Hematology, Pharmacology +12

Efficacy and Safety of a Low‐Molecular‐Weight Heparin and Standard Unfractionated Heparin for Prophylaxis of Postoperative Venous Thromboembolism: European Multicenter Trial

V V Kakkar, O. Boeckl, B Boneu et al. · World Journal of Surgery · 1997 · 98 citations

Medicine, Hematology, Perioperative Medicine +16

Substitution therapy with an antithrombin III concentrate in shock and DIC

B. Blauhut, S Necek, H Vinazzer et al. · Thrombosis Research · 1982 · 92 citations

Medicine, Hematology, Pharmacotherapy +14

Dose-Dependent Influence of Acetylsalicylic Acid on Platelet Functions and Plasmatic Coagulation Factors

D Loew, H Vinazzer · Haemostasis · 2009 · 67 citations

Medicine, Pharmacology, Pharmacotherapy +5